Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Entrada Therapeutics (TRDA) Asset Utilization Ratio (2023 - 2025)

Entrada Therapeutics has reported Asset Utilization Ratio over the past 3 years, most recently at 0.06 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.06 for Q4 2025, down 83.5% from a year ago — trailing twelve months through Dec 2025 was 0.06 (down 83.5% YoY), and the annual figure for FY2025 was 0.06, down 86.71%.
  • Asset Utilization Ratio for Q4 2025 was 0.06 at Entrada Therapeutics, down from 0.14 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for TRDA hit a ceiling of 0.44 in Q2 2024 and a floor of 0.06 in Q4 2025.
  • Median Asset Utilization Ratio over the past 3 years was 0.22 (2023), compared with a mean of 0.24.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 389.05% in 2024 and later tumbled 83.5% in 2025.
  • Entrada Therapeutics' Asset Utilization Ratio stood at 0.27 in 2023, then surged by 44.23% to 0.39 in 2024, then tumbled by 83.5% to 0.06 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.06 (Q4 2025), 0.14 (Q3 2025), and 0.17 (Q2 2025) per Business Quant data.